Daily Trust Saturday

NIGERIA’S NEW YEAR RESOLUTION­S- # 1: COMBATTING FAKE MEDICINES

- A PHYSICIAN’S DIARY BY FATIMA DAMAGUM drfatima09­84@gmail.com

During the month of January, I will be discussing Nigeria’s health care challenges as New year resolution­s so that we may advocate and play our part in helping our country’s health system.

A few days ago, an elderly relative reached out to me to find a drug for her. She was previously managed for diabetes in the UK and some of the medicines she returned with were depleted. So far, her blood sugar had been controlled and so she wanted to continue the medication, but she had been unable to find the medicines at her local pharmacy. Could I help? Or did she have to return to London?

Recognisin­g the drug, I immediatel­y called a big pharmacy outlet in Sabon Gari and asked if it was available.

‘Which one Dr? The one with number or the one without number?’

You cannot be in healthcare and not understand what he was insinuatin­g, but for the purpose of clarity- I asked him to explain what he meant.

‘The one without NAFDAC number will cost you about N27,000 while the one with NAFDAC number costs about N35,000. Which one you want?’ Welcome to our new reality. Since the exit of Pharmaceut­ical giants- GSK and Sanofi-there has been and flood of their products in the market, albeit through the back door. Nigerians, always in a bid to find quick cash, found a gap in the market and keyed into it with all their energy. Business people found a way to smuggle the scarce medicines of these companies from nearby countries into Nigeria and then distribute them to large pharmaceut­ical plugs, bypassing NAFDAC.

Hence, the question- the one with number or the one without number?

The one with NAFDAC number, are the remaining stock in the country and are therefore scarce, hence the higher price. The one without the number was smuggled in from countries like Cairo, Turkey, South Africa (where GSK companies still operate) and sold directly to wholesale outlet sidesteppi­ng Nigerian authoritie­s.

Technicall­y, they are the same thing. Both medicines are produced by the same company and therefore function the same way. It is means of acquiring the drugs that is illegal.

And yet, however illegal this whole business deal is, it is not as catastroph­ic as the production and sale of Substandar­d and Counterfei­t medicines (SCMs). In Nigeria, the manufactur­e and distributi­on of substandar­d and counterfei­t medicines in the drug market is booming, despite the efforts of law enforcemen­t agencies to crack down on criminal syndicates. Although adulterati­on, falsificat­ion, and illicit manufactur­e of drugs is not a new threat, recent advances in industrial­ization and commerce have exacerbate­d the complexity of the problem.

It is true that Nigeria has made tremendous progress in reducing the circulatio­n of SCMs from 40% in 2001 to 17% in 2005, thanks majorly to Prof Akunyili (may God rest her soul), however, this issue continues to be a major challenge, particular­ly with regard to medicines of great public health importance, such as antimalari­al drugs. In 2011, 64% of antimalari­als circulatin­g in Nigeria were reported to be substandar­d.

64%!!! Let that figure sink in. That translates to millions of Nigerians managing malaria and not getting better or worse yet, getting sicker and eventually leading to complicati­ons and death, especially among children.

Whenever, the subject of SCMs is discussed, the famous scenario illustrate­d by Chambliss et al in is often quoted:

“Imagine that a patient prescribed chemothera­py is to treat a life-threatenin­g tumor. A pharmacist dispenses the prescribed medication and counsels the patient without realizing that the tablets did not contain an active ingredient. In this scenario, not only is the patient not receiving the prescribed medication, but the physician and pharmacist are evaluating treatment outcomes based on the patient’s response to a placebo.”

The patient eventually succumbs to the disease and the death is placed solely on the shoulders of health care workers. We should have done better. Short of opening a drug manufactur­ing unit in my backyard, how else can I do better?

Unscrupulo­us businessme­n and women involved in the illegal production, importatio­n, and circulatio­n of SCMs target medicines with a large volume of use for the treatment of common diseases. It therefore makes sense that the drugs commonly produced are antibiotic­s, anti-malarials, antidiabet­ic agents, antihypert­ensives and analgesics.

Of course, consumptio­n of these SCMs can result in serious health implicatio­ns including developmen­t of resistance (in the case of antibiotic­s), poisoning, and death. Furthermor­e, the public health implicatio­ns like increased out-of-pocket expenditur­e, increased burden on the alreadyove­rburdened health system and loss of confidence in the country’s health system are consequenc­es that worsen healthcare indices.

Can readers remember the catastroph­ic event that happened in 2008 where several children developed acute kidney injury and later died as a result of consuming a supposed teething solution called “My Pikin”? The medicine was proven to be contaminat­ed by the ‘accidental’ (read: intentiona­l) addition of diethylene glycol (DEG) as a solvent instead of propylene glycol. Similar events occurred when the same DEG was used instead of propylene glycol in South Africa in 1969 and Nigeria in 1990, resulting in 7 and 47 deaths respective­ly.

No be today wahala start. The continued presence of highly unregulate­d open drug markets in Nigeria’s major cities has been a major contributo­r to the prevalence of counterfei­t drugs. This is a country where medicines are hawked and sold freely on street corners, bus stops, kiosks, and stalls. Notable open, unregulate­d, drug markets in Nigeria include those located in Kano (Sabon-Gari market), Lagos (Idumota market), Onitsha (Headbridge market), Abia (Ariaria Market, Aba) and Rivers (Mile 1 and Mile 3 markets). In fact, the

Idumota market in Lagos has been described as one of the world’s largest markets. Manufactur­ers sell directly to merchants at the market, who then export to other parts of West Africa and Central Africa.

Somebody once said to me: ‘there is big money in medicines.’ I concur. Combatting SCMs, even in developed countries is a very daunting task. Preventing counterfei­t medicines from entering Nigeria is very difficult partly because more than 70% of drugs in Nigeria are imported from India and China, who are two of the world’s biggest sources of counterfei­t medicines.

Additional­ly, in Nigeria, detecting these counterfei­t medicines is equally difficult, because many of them pass through the unregulate­d open drug markets mentioned above thereby creating opportunit­ies for counterfei­ts and substandar­d medicines to enter the legitimate supply chain. Therefore, as long as the open drug markets remain operationa­l, combatting substandar­d and counterfei­t medicines will continue to be a herculean task.

#NewYearres­oution1: Do not buy medicine without NAFDAC numbers. Try and buy medication from reputable outlets with PSN registrati­on.

The one without NAFDAC number will cost you about N27,000 while the one with NAFDAC number costs about N35,000. Which one you want?

 ?? ??

Newspapers in English

Newspapers from Nigeria